Aspirin Dose and Atherosclerosis in Patients With Metabolic Syndrome

NCT00272311 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Cardiovascular Diseases
Metabolic Syndrome X
Atherosclerosis

Interventions

DRUG: Aspirin

Sponsor

Florida Atlantic University

Collaborators

[object Object]